Secondary structure of anthrax lethal toxin proteins and their interaction with large unilamellar vesicles: a fourier-transform infrared spectroscopy approach

Biochemistry
X M WangV Cabiaux

Abstract

Attenuated total reflection Fourier transform infrared spectroscopy has been used to study the secondary structure of anthrax lethal toxin proteins: protective antigen (PA) and lethal factor (LF), as a function of pH in the absence and in the presence of phospholipid vesicles. We first characterized the binding of LF and PA to the lipid membrane and demonstrated the strong pH dependence of the association of PA and LF to the lipid bilayer as well as the effect of pH neutralization on this binding. Binding of LF to the lipid membrane can be, at least partially, reversed when the pH is brought to neutral whereas in the same conditions PA binding is irreversible. Characterization of the conformational changes undergone by PA and LF upon pH lowering, lipid binding, and, in the case of LF, reversal of binding was carried out (i) by determining the secondary structure of the proteins and (ii) by evaluating their ability to undergo an hydrogen/deuterium exchange.

References

Mar 26, 1992·Biochimica Et Biophysica Acta·E London
Oct 1, 1985·The Biochemical Journal·C MontecuccoM Tomasi
Dec 1, 1980·The Journal of Cell Biology·K Sandvig, S Olsnes
Jan 1, 1995·Critical Reviews in Biochemistry and Molecular Biology·M Jackson, H H Mantsch
Oct 1, 1993·Journal of General Microbiology·C PezardM Mock

❮ Previous
Next ❯

Citations

Jan 7, 2004·Journal of Microbiological Methods·Anne-Marie MelinBertille de Barbeyrac
Oct 12, 2001·Toxicon : Official Journal of the International Society on Toxinology·F Brossier, M Mock
Mar 11, 1998·International Journal of Biological Macromolecules·V CabiauxJ M Ruysschaert
Jul 7, 1999·Biochimica Et Biophysica Acta·E GoormaghtighJ M Ruysschaert
Jan 23, 1999·Current Opinion in Structural Biology·D B Lacy, R C Stevens
Dec 14, 1999·Microbes and Infection·S F Little, B E Ivins
Dec 22, 1999·European Journal of Biochemistry·C PagliacciaV Cabiaux
Feb 24, 2001·Cellular Microbiology·C Guidi-RontaniV Cabiaux
Oct 23, 2003·Annual Review of Cell and Developmental Biology·R John Collier, John A T Young
Jun 7, 2005·Advanced Drug Delivery Reviews·Robert N Brey
May 19, 2016·The Journal of Physical Chemistry. B·Qichi Hu, Julia Laskin
Nov 9, 2001·Nature·A D PanniferR C Liddington
Aug 2, 2021·Biochimica Et Biophysica Acta. Biomembranes·Wenxing Liu, Ekaterina M Nestorovich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.